Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis.
about
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateTapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsMethotrexate utilization in Rheumatoid arthritis. A register-based cohort-study of treatment re-starts after gabs of at least 90 days[Rheumatoid arthritis].When to initiate and discontinue biologic treatments for rheumatoid arthritis?German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.Optimizing the expediency of TNFi in rheumatoid arthritis: offering a TNFi holiday in patients having reached low-disease activity in the maintenance phase.Key findings from studies of methotrexate tapering and withdrawal in rheumatoid arthritis.Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis.What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations.IL‑22 expression is increased variedly in the initial phase, onset and chronic phase of a pristane‑induced arthritis rat model.Guidelines for the drug treatment of rheumatoid arthritis.Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial.Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.[Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].
P2860
Q26859134-56E02889-9849-4F57-88A9-B9024DF8CAF6Q30249836-8FF0ACBE-8633-4A63-8855-6EE3DE88F38AQ34110066-0931558C-213D-457F-82A1-99018CD975F2Q35761884-370F8BA0-E050-4A06-B735-4C80C56BF90AQ36241682-E626F01B-65EC-4376-8562-119C9E1E8341Q37831972-95ED35F5-F9AF-4A8E-8302-A14D975212AAQ38128726-CFFE306D-FAC7-4175-AAE4-60CA83534A17Q38264653-3A130642-BFC8-4088-832E-FBB54ABE818BQ38569688-35E3E16E-3CEB-4837-AD7A-61593BFB69D6Q38598776-5A3FD692-965B-4287-98E1-D5EF16B2CE3DQ38815746-9E9D43F7-C224-4B2F-80F9-25FBD07D4FCFQ38955830-0A751922-F02E-41D9-8C43-73FB694BE40CQ39669606-25F0E0CF-C461-404A-B237-4EE258BE086AQ41026649-3E010D1D-724D-4718-9D6B-17E655C222A9Q42273153-F97D59F3-BB7F-406F-9178-69ACD074EA64Q42347098-F7B5D15E-A07E-49F3-8340-07B8F2475E40Q43675571-9E6417EB-A458-4955-8821-ED8FDD46E024Q45975049-1A8019C9-FCD3-43EC-9234-06D957A964C5Q50981759-E0D1849E-3209-4AE0-AB8D-F9F0A30991F4Q52869895-C052963D-A70F-415B-813E-5AA8F3344A14Q53463643-5711C12D-DA49-49CD-ABAA-DD69F1E7921D
P2860
Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@en
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@nl
type
label
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@en
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@nl
prefLabel
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@en
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@nl
P2093
P356
P1476
Withdrawal of disease-modifyin ...... atic review and meta-analysis.
@en
P2093
Alison Richards
Chris Deighton
David Scott
Rachel O'Mahony
P304
P356
10.1136/ARD.2008.105577
P407
P577
2009-02-17T00:00:00Z